outlook hand morning, and Michael everyone. and my for as and Systems' we'll our year detailed share good of for a Turner, our over quarter begin then guidance financial the to call and ahead. XD XXXX, company's well performance the on focusing fourth some what on Russell, you, during as XXXX. for on After XXXX more the discussion XXXX that, year thoughts results be full morning I'll achievements in CFO, Thank I'll this with and comments I'll
with financial that our me the very upfront ultimately a headwinds and turn given the we of year. of at to proud quick recap set slide while that, last start a what original common I'll companies we of ours. ahead which say goals and It's the five particularly to these the I'm factors, of to achieved, directly was of that taking of as short in possible our company relate that the with let of few response year, beginning many So unique in our were which and to clear about we're year, encountered important them. one we they be as during view as to actions came year
supply anticipated were First, rapid as expected. chain they problems which rise of demand inflation, throughout while what COVID variety driven Much the however, elective medical issues and we than worse was had throughout improve the they to consumer in for were reduced impactful, continued a nagging the year more no year, procedures.
we orthodontic groceries, acutely for necessities most shifted Systems, our higher labor in the material trends. gross products, as cost created in opportunities cars. their which and significant this declined spending basic as a pricing challenges itself lagged XD clothing felt homes margins At such times in consumers inflation as business, in This our and at which their costs more manifested also as energy our significantly and to slowdown profit dental
more Second, inventory. equipment industrial cautious the some uncertainty in space and defer particularly at manufacturing economic recession in investments and customers, our new of fears and become to
to on dampened shutdowns in but halt Russia, improved markets and COVID disrupted States, restrictions by general. into in in led Third, daily to factory situation finally, sales for economic of while not the the tragic activity only key And in also life. continue Asia war demand United parts Ukraine be the us European
be and prove costs number Systems a XXXX, challenging staying our delivering year. our factors, manage, key global will commend these to well updated efficiencies. entire drive team want to on We Thanks near-term I a external of XD of very operational you financial guidance took into and concrete to Baking solid hard to control we to customer and steps nimble had working a commitments. half for second to their efforts. our
portfolio, we of XXXX consider things extraordinarily to in XXXX most the place our clear areas, emphasize would Systems. an and corporate put and to year can we we such regenerative strategic to indeed, be year leveraged foundation made regulatory be One number our year be when business and build to productive invested the for product support continuing that a investment company's XD with that world-class Last future important our infrastructure the that our refreshing key proved you And for for medicine future. it growth. a of to regard was it an during year, it in company improving
these customers on harvesting and that revenue. I'm speak a some of new new a in moment. will benefits sources form I'll already investments wins pleased to Capitalizing the for the of we're say important of about that early be more key in of focus in and new us technologies, XXXX, these
also important in during as emerging note such XXXX regenerative medicine. to highly It's attractive businesses, heavily that the we invested
two additive our production the promises value over forefront the and stakeholders. to While these investment XXXX spending growth results, these investments course expenses are needs assure new XXXX balancing stay the prudently this of of markets fall. to the with our adoption customers well efficiency continue are to entirely of as the to pre-commercial that support acceleration order and in impact beyond, We're positioned at and and committed for largely decision the dynamic the years. of I'm in right our future become opening their And long-term. cost the for will while ability are all given needed increasingly to their Systems, of absolutely apparent These environments XD impacted initiatives efforts today, of next over continued deliver strategic the this manufacturing of
Slide X. to Moving
and product materials this and us hardware, XXXX, already and our printer important software. During crucially focus industry-leading our achieved particular, including comprehensive several effort they've In a our most investment teams milestones undertook front. important on platforms for a expanding hardware portfolio, refresh critical was to updating
Last fastest printer is and Dual, that's stereolithography year, format, polymer and our XXX all-new enjoyed platform from and automotive large largest, and high-volume an the launched the most precise ideal for SLA the XXX we This printer has enthusiastic our SLA reception aerospace industrial, applications. market, fastest-ever customers. SLA on
high-temperature of the we team XX,XXX producing Alpine our the is week, last team product purchased FX systems announced SLA phase. our materials. during jigs. bills their will parts, composite Just as XD to use tunnel having Systems complex accelerate new The bonding testing has team extensively well SLA The and XXX four after manufactured beta currently parts per tools FX printing year using XXX of its Alpine aerodynamic BWT small additively wind equipment tested as and for
we're the market. SLA a to design of XD the The growth, capability to strategic building evolution from systems, by at illustration perfect the the through products drive rapid innovation ability lab customer is XXX accelerating new
new operating close ago, in with precision high-quality to platform ideally environments. levels pure the wax in two industry-leading speed users produce printer, customization our collaboration of end responded XXXXW weeks complex, we It was our small suited Plus, This is mass production which to applications. and major jewelry and with introduced upgrade other to needs upgraded developed printed patterns specifically customers and is precision. jewelry a casting directly designed And jetting for MJP the XD of
early earlier, year. As of cycle XXXX the and platforms I rapid near-term We'll the the MJP will the of investments. XXXX refreshed during to new number innovation. The accelerate examples launch key performance noted XXX a two for are these with for be harvest we're focus technology in investments upgrades XXXX making a of benefits scheduled of throughout SLA customer-focused
seven. moving slide to Now
platforms, to Polar, our further investments, of unique which Titan, offerings these optimistic expansion potential three each in XXXX, new early-stage legacy in about acquiring very organic markets. of addition production our these in Kumovis and DP In for specific We're offer platforms, the by of systems. accelerated each advantages the hardware print we printing
technologies early accomplish. what still stages While can launch, exciting of signs in seeing the these already we're revolutionary of
a take share Let to example one with me minute you.
Group, executed clinical Hospital Just Austria's we printed week, such as a major polymers, from Healthcare the first witnessed at of implantation a PEEK of a Salzburg, using team materials University milestone Solutions specifically Kumovis PEEK. when was printer high-performance polymeric our of last in the or for achievement plate This XD printer. grade developed medical-grade cranial for Polyetheretherketone a medical manufactured precision printing surgical
an a Using implant cranial the to needs. only surgical was incident, related match In of printed create the anatomical Kumovis profile to printer care large unusually point size the customized and section installed a at been of not precisely printing internal lightweight important porous critically techniques. a brain. replacement that patient's hospital, scale manufacturing suitable and cranial have team XD the specific physiological also given it inside for protection needed would the outcome the plate this the honeycomb plate traditional structure, of with to the by impossible using But
implant of integrating point-of-care overall are the This our properties Kumovis their personalized type application, acquired and material, PEEK into which why is exactly of on performance takes patient-specific biocompatible portfolio. and advantage we platform
spectrum decade As digital this processes patient targeted solution from needs technology polymeric that now replacement advance and joint pioneered options of match to each and titanium cobalt medical-grade orthopedic applications, positioned ranging for the the of care surgeons last uniquely printed which we've customized and our spinal, in health business. cranial bone a and for is provide chrome over other to the to precisely using we're full comes tools online,
of of the in faster process, key and care remain further the world. platform, say and our required the in These patients I'm technology lower combined with rapidly to range orthopedic When the long-term accelerate so. in we're patients leader which growing application now workflows existing applications, proud solutions will is making the sustained to provide software better, to Oqton we're around drive our in will cost automate for health investments ability growth this which standardize outcomes and market, business. a this orthopedic to
portfolio, complete we'll XD customers is solutions Systems in scale true remain in to move we Print wishing forward to our manufacturing. for with choice the partner clear. of innovative of lineup most product potential offer serial will industry other continue As the XD of and goal additive investments vast and the these our unlock the
Slide Moving X. to now
area important was focus during medicine. regenerative investment strategically Another XXXX of
for XD believe additive As convinced Moreover, to I've the frontier manufacturing. is I'm next is that regenerative growth previously, Systems uniquely industry. you emerging lead I this shared positioned with medicine that
no XX-year-plus of quality and propensity track through high-resolution record upon developing We a other our combine of claim, hands-on a company a deep material human engineering, foundation draw gained regulatory applications, Therapeutics. through and of science, multiyear expertise to acquisitions XD with United printing organ can strategic experience in and strong tissue including set attributes that both in partnership
that partner, milestones business. remarkable the extraordinary publicly represents in a the systems Over object XD printed United achieved complex of biotech offer manufactured. our months, program last animal in this regenerative that medicine potential achievement has In gas unveiled the emerging a growth already preview engineering development XX XXXX long-time lung Therapeutics, demonstrated exchange into printed XD has extraordinary our functional models. ever most This scaffold
believe what we in just could Based made last printed a upon five human within trials time progress years, we envisioned that back enter lungs our to significantly accelerated XXXX. transplantation XD year, frame
and develop Also the organ-on-a-chip remind development leveraging for formation Bio, traditional a a drug engaged be marketers I our when not printing chips of in companies and in instead by will use that unique XD with Bio HVIOS owned to and vascularized and Systemic HVIOS to with major disease called in will pharmaceutical tailored technology pharmaceutical want functions, jointly Bio directly expertise of announced and we everyone biotech a industry. directly organ XXXX, develop in specific startup wholly ships to materials vendor partner printers the a Systemic discovery pharmaceutical companies Systemic tissue discovery. company drug manufacture to to
our the the valuation that result for company's appreciate that to company's drive baseline re-rating this major profitability the all change. can could we our pharmaceutical would customized biotech as a you sure high-value well of by I'm increase from becoming supplier as products multiple of industry substantial
is team more having to to with actively and this look we in in forward potential commercial future. near speak, discussions customers. front the I As with you engaged Bio Systemic our partners on share news
the effort we had biocompatible that's And new XD just anatomy patient-derived printing success to a hydrogel achieved research printing manufacture tissue in organs regenerative the direct we've XD mimic and of and outcome program human scaffolds. improved surgical scaffolds, ago, can materials and we announced a This and variety outcomes is internal technology, bioprinting in two milestone, another of deliver combining cells development a patient's a vascularized applications. weeks physiology
we that for up diagnosed Systems could reconstruction could address. It application option of market is tissue. improved year. millions product a cancer with also positioned under The dramatically uniquely is breakthrough first XD have new printed each women This development opportunity XD regenerative implant-based breast significant offer to to open
A new high-growth key point consistent we we're believe offer is industrial, additions with only pursuing product returns our ongoing R&D company's to solutions our programs attractive and provide markets. our initiatives regarding high-value, mission investment to are care and to that portfolio health application-focused and
us Given and maintained we balance heavy despite operating focus utilize headwinds market. as its our spending importance, our investment target control XXXX and our greater-than-expected key to carefully, investment Doing during softness well geopolitical our strategic as costs, so requires in macroeconomic very sheet. orthodontic our strong
solid for we'll able a supported will many come. we I XXXX during remain XXXX and the that that profitability to continue years in to fund to building growth leverage for future be and are convinced foundation programs
slide internal performance to activities Moving have provided several through important now benefits, highlight continue move to already to we recent as like with XXXX. and do we'll so nine. that us I'd
Last better year, portfolio. meaningful in we company's aligning emerging chain our operations our with and supply operating achieved product and profile manufacturing success
this our XXXX, second to South we onto as and step This part transition platforms the ahead margins delivery for elevated explains printing significant major of reliability our quality costs some already amount in-sourcing half our need, levels of of a product impacted inventory our one-time end us take required to positively the by polymer a our The as operations. and process which the During at into change books has inventory completed improved manufacturing well our incur year. Carolina in customers. in of gross
to on excellence targets, you efficiency. financial cost my In the track XXXX, of operational our as pace laser-focused we driving product be that accelerate have performance that we new commitment releases and will
operations our profit important software platforms the platforms, our our is long-term an by a and now the XXXX our this profile which organization, often initiative aligning bring announced on product engineering portfolio to manufacturing that for we restructuring improve our three European metals Yesterday, better market. in process, value step highest will and under consolidated streamlining focusing that
of throughout synergies allow for is us and activities cost will planning and achieve actions, integration These which Michael the detail XXXX later you. optimization XXXX to beyond, in conducted will culmination as significant
of and further product reorganization of Beyond Zuiker, management, of improvements XXXX, these discrete laid measures groundwork new and fourth recently aligned a executive design, for now manufacturing procurement, to by logistics we engineering, Systems the on maximize a take We've are to undertaking role. XD efficiency, quarter all who functions. the major operational operations engineering and during single my member team, this Joe company Dr. our joined
product a engineering excellence. element drive our from Their our organization-wide leadership, full-scale to portfolio. mission will Joe's primary seamless progression together operations be operational an work every Under and for focus to ensure on design will manufacturing to teams in
full half will assuming year present to Michael, to new our shortly, for my prudently outlook In like on which that the Before all slowdown guidance, market we're provide second call throughout considerable Industrial dental you Dental, XXXX. persist over handing we in experienced markets our across I'd and broad XXXX XXXX. strength see of perspective other to that Michael our in we Solutions the of segments. will Outside Healthcare virtually the
we our throughout positive costs us for to Putting may growth cash mid-single for and for together, to the by restructuring year, achieve that full efficiencies drive any in growth allow profile will rates one-time the consolidated the supported operational This flow excluding incur. cost XXXX EBITDA non-dental we XXXX free adjusted generate should that in expect the digits, mid-teens plus this growth revenue all markets.
of medicine I continued investments R&D XXXX and our reflects to including development, growth business, in world-class areas product guidance fully a creating that business. new regenerative our emphasize want
activities All which designed are of support critically important to future growth.
our enter over years. so XXXX, committed never last put hard we're in expertise New been leadership in given worked In technology, with leadership printing the Year, excited these we to the I've drive we've to place industry, more few As confident position. our in results operational and line position particularly foundation and in financial company's XD the application
Earlier open note have XD Justice investigation I'd into previously XXXX. XD place took alleged Systems violations and announced remarks, additional to US XXXX of Commerce my concluding like these Systems week, by control with that before export the State, one Finally, agencies and Department between their topic. this that settled
matter remedial to controls committed reached as a disclosed compliance We time consent our enhance XD to settlement filings as to three-year well this in our certain for SEC its of some with part Systems monetary subject now. the will export as is the settlement, be Under agency, pleased civil have remains program. continuing agreement. a penalties The company measures to
forward, now we'll Systems and compliance culture, processes established the of building that with continue upon. we've I'm proud that very and Looking infrastructure XD
a We are leader not complex element all fully meeting in what but committed being is today. all essential only required standards, to an true businesses of global
like I'd to our the that, CFO. Turner, over Michael? Michael With call turn to
